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Simkania negevensis, a recently discovered Chlamydia-like organism, has 
been associated with respiratory infections such as pneumonia, bronchiolitis and 
chronic obstructive pulmonary disease in children and adults. The aim of the present 
study was to evaluate S. negevensis in the etiology of pediatric community-acquired 
pneumonia, bronchiolitis and asthma exacerbation in our region. Overall, 102 pa-
tients and 46 healthy controls were included in the study. S. negevensis was investi-
gated by real time PCR (Primer Design, UK) in nasopharyngeal swab samples. 
It failed to be detected in either the study or control group. In conclusion, our results 
suggest that S. negevensis is not an important respiratory pathogen in our region.
Keywords: Simkania negevensis in Turkey, pediatric pneumonia, bronchioli-
tis, exacerbation of asthma
Introduction
Simkania negevensis was fi rst defi ned in 1993 [1]. S. negevensis, is an obli-
gate intracellular microorganism that is similar to Chlamydia. It has been recom-
mended that S. negevensis, formerly called “Z” or “Simkania Z”, be named as a 
new family under Simkaniacea. Along with the globally varying seroprevalence 
of S. negevensis, there exists a high rate of seropositivity for some populations 
and it is associated with various respiratory diseases [2]. S. negevensis has been 
proven to have an association with acute bronchiolitis [3], community-acquired 
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pneumonia in adults [4] and acute exacerbation of chronic obstructive pulmo-
nary disease (COPD) [5]. It is not known to be existent in Turkey.
The aim of this study was to explore the existence of S. negevensis as an 
etiologic agent for children applying with acute bronchiolitis, community- 
acquired pneumonia and acute exacerbation of asthma.
Materials and Methods
The study was conducted prospectively from February 2012 to April 2013 
in Erciyes University Faculty of Medicine Children’s Health and Diseases De-
partment. One hundred and two in the age range of 1 month–10 years with diag-
nosed pneumonia, bronchiolitis and exacerbation of asthma who were being 
medically treated at the polyclinics and services of Erciyes University Faculty 
of Medicine Children’s Health and Diseases Department were involved in the 
study. Additionally, a control group consisting of 46 healthy children was formed. 
The children were classifi ed into 4 groups according to the complaint at the time 
of application, evidences of the physical consultation and posterior-anterior lung 
graphy. Group 1: Pneumonia group: Patients applying with cough or respira-
tory problem according to WHO, with their age taken into consideration, having 
tachypnoea or retraction without wheezing and having abnormal results on lung 
graphy were regarded as belonging to the Pneumonia group. Group 2: Bronchi-
olitis Group: The clinical state of children under the age of 3 characterized by 
wheezing, tachypnoea and retractions was regarded as Bronchiolitis. Group 3: 
Exacerbation of Asthma Group: This group was formed of patients who had 
been previously diagnosed as having asthma and came with exacerbations during 
treatment. Group 4: Control Group: Children without respiratory problems 
who were totally healthy. Patients with a story of antibiotic usage during the last 
72 hours, who had been medicated while staying in hospital during the last 15 
days and who had latent chronic diseases were not involved in the study.
Nasopharyngeal swab specimens which were taken with a sterile throat 
culture swab were placed into an eppendorf tube and 1.5 ml of PBS (Phosphate 
Buffer Solution) was added. After being closed, the tube was kept at a tempera-
ture of –80 °C until the examination date of the specimens.
Nucleic acid isolation for all of the specimens was made using a QIA sym-
phony DSP Virus/Pathogen Midi Kit Version 1 (Qiagen, Germany), in accord-
ance with the kit procedure. During nucleic acid isolation procedure internal con-
trol (plasmid DNA) for control of PCR inhibition was added to each tube. For 
genome quantifi cation of S. negevensis a real time PCR kit (Primer Design, UK) 
was used [6]. The primers of kit amplifi ed 117 bp fragment of the 16S and 23S 
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ribosomal RNA of S. negevensis. Positive control (plasmid DNA) and negative 
control were also studied. For all of the specimens and the controls the PCR pro-
cess was conducted with a Rotor-Gene Q5 plex device (Qiagen, Germany) for the 
detection of genome.
Results
Out of the 102 cases involved in the patient group, 45 (44%) belonged to the 
Pneumonia group, 32 (31%) belonged to the Acute Bronchiolitis group and 25 
(25%) belonged to the Exacerbation of Asthma group. Out of the 45 patients in 
the Pneumonia group 19 (42.2%) were girls and 26 (57.8%) were boys. Out of the 
32 patients in the Acute Bronchiolitis group 15 (46.9%) were girls and 17 (53.1%) 
were boys. Out of the 25 patients in the Exacerbation of Asthma group 11 (44%) 
were girls and 14 (56%) were boys. The average age of the Pneumonia group was 
46 months (±38), the average age of the Bronchiolitis group was 14 months (±11) 
and the average age of the Exacerbation of Asthma group was 55 months (±32). 
The average age of all of the patient groups was 38±35 months and that of the 
control group was 39±31 months. S. negevensis could not be diagnosed with PCR 
in either the patient groups or the control group. Amplifi cation of the positive 
control was good. Amplifi cation of the internal controls was checked and all of 
them were amplifi ed. Then there was no PCR inhibition in the specimens.
Discussion
Simkania negevensis has been identifi ed as an effective agent in children 
and adults in both the healthy population and in sufferers of respiratory prob-
lems. The seropositivity of S. negevensis in the healthy population in Israel, the 
United Kingdom and Denmark has been determined to be %46–80 [6–8].
In a study by Kahane et al. [3] conducted in Israel, using culture and/or 
the PCR method, S. negevensis was researched in specimens of nasopharyngeal 
wash taken from 120 infants with bronchiolitis with an age range of 2 weeks to 
12 months. The positivity rate of S. negevensis was calculated to be 28% while 
S. negevensis could not be detected in the control group consisting of 56 people 
and a statistically signifi cant difference was found when the two groups were 
compared [3]. Greenberg et al. [9] reported that they identifi ed a positivity rate 
of 64% for S. negevensis with the PCR method on the specimens taken from 22 
infants with bronchiolitis in Canada [9]. In a study conducted by Kumar et al. [2] 
in Brooklyn, NY, S. negevensis was researched in a group of patients consisting 
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of 188 children and adults (aged between 2 weeks–83 years) diagnosed with asth-
ma, bronchiolitis and pneumonia. A control group of 110 healthy subjects who 
were of similar age was also included. It was reported that S. negevensis was 
detected in 17% of the patients and 23% of the control group in the nasopharyn-
geal swab material with the PCR method [2]. In a study by Korppi et al. [10], 
which was conducted in Finland, they searched for S. negevensis in a group of 
104 patients with recent diagnosis of asthma who were aged between 1–6 years. 
A control group of 120 subjects was also included. IgG, IgA and IgM were 
searched in the blood specimens with microimmunofl uorescence (MIF) test. 
S. negevensis was found to be positive at a rate of 16%. S. negevensis was proven 
to cause infection in pre-school children but no correlation with asthma was 
 detected [10]. In a recent study, S. negevensis was investigated with the PCR 
method in the bronchoalveolar lavage fl uids of 41 lung transplantation patients. 
Surprisingly positivity was detected in 40 of them and this situation was shown 
to be associated with acute rejection [11]. In a recent study in Israel, S. negevensis 
was detected with the PCR in 91% of 34 children with pneumonia. The research-
ers detected S. negevensis in 88% of the drinking water specimens taken from 
the houses of these children leading them to assert that this microorganism 
was widespread in the environment of the children and that the contamination 
might have occurred from drinking water [12]. In our study, nasopharyngeal 
swab specimens were taken from a patients group of 102 subjects out of which 45 
had pneumonia, 32 had acute bronchiolitis and 25 had exacerbation of asthma 
and from a control group of 46 healthy people. S. negevensis was searched for 
using the PCR method. It was detected neither in the patient groups nor in the 
control group. The fi ndings of this study contradict those of the above-mentioned 
studies.
Simkania negevensis has been reported to be frequently seen in Israel, 
North America and Western Europe, whereas no regional limitation has been 
made [3, 6–8]. For instance, in a study by Yamaguchi et al. [13] conducted in 
 Japan in a group of 588 healthy people, S. negevensis specifi c IgG was searched 
for with the MIF technique and a positivity rate of 4.3% was found in healthy 
volunteers. For this study group, in only 3 (1%) of 296 people younger than 19 
years of age was positivity detected and S. negevensis frequency was found to 
increase with older age [13]. In the study by Nascimento-Carvalho et al. [14] 
which was conducted in Brazil, they detected S. negevensis as serologically pos-
itive (IgG and IgM) in only 3 (1.6%) of 184 children under 5 years of age who 
were all  being treated in hospital for community acquired pneumonia [14]. Con-
sequently, the above-mentioned researchers showed that S. negevensis is a real 
but also a rare cause of lower respiratory tract infection in their regions. They re-
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ported that this situation was due to the variations in the global seroprevalence 
of S. negevensis [13, 14]. In our study, S. negevensis could not be detected either 
in the patients group or in the control group. Our fi ndings support the variations 
in the geographic distribution of S. negevensis.
Some limitations are found in this trial. First, the number of children in the 
study group was limited. Secondly, we only use PCR method because there is no 
commercial kit for detecting S. negevensis autoantibodies worldwide.
Consequently, S. negevensis, which has been recently defi ned and whose 
prevalence worldwide varies from country to country or amongst age groups, 
was not detected in the study conducted in our region. This situation led us to the 
opinion that even if S. negevensis exists in our region, it is an extremely rare 
agent in lower respiratory tract infections. In future studies, the real incidence of 
S. negevensis can be detected worldwide.
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